Brewing prescription drug ingredients like they were beer
Backed by US$120 million in venture funding, Stanford professor Christina Smolke’s company Antheia just completed its first scaled production of a key drug ingredient.
Alex Knapp, Forbes Staff
This company just raised US$71 million to see the forest for the trees within a patient’s cells
Spatial biology startup Resolve Biosciences is building up capital.
Prime Movers Lab raises a US$500 million early growth fund to invest in breakthrough science
The new fund will be focused on startups in energy, manufacturing, agriculture, healthcare, satellites and more.